跳至主要内容
临床试验/ITMCTR2200005923
ITMCTR2200005923尚未招募1 期

Evidence-based clinical research on the intervention of activating blood circulation and removing toxicity herbs in patients with borderline coronary lesions

Xiyuan Hospital of China Academy of Chinese Medical Sciences0 个研究点开始时间: 待定最近更新:

试验速览

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional study

入排标准

性别
Male

入选标准

  • (1)Patients with coronary artery bordeline lesions confirmed by coronary angiography or coronary computed tomographic angiography with stenosis of at least one major coronary artery lumen between 50% and 70%;
  • (2) Patients aged 18–80 years.
  • (3) Patients with heart function grading of NYHA grade?-?
  • (4) Patients conform to the TCM standard of blood stasis syndrome
  • (5) Patients will be informed about the trial and should voluntarily sign the consent form.

排除标准

  • (1) Patients who had previously undergone coronary stent implantation, coronary artery bypass grafting or acute myocardial infarction within 3 months;
  • (2) Patients with diffuse lesions throughout the diseased vessels;
  • (3) Those who had previously undergone other cardiac operations, such as valve replacement;
  • (4) Patients with severe heart, liver and renal insufficiency, who are not suitable for coronary angiography and related examination and treatment;
  • (5) Persons suffering from mental disorders;
  • (6) Persons suffering from hepatitis, tuberculosis, AIDS and other infectious diseases;
  • (7) Allergic constitution;
  • (8) Pregnant and lactating women;
  • (9) Those whose life expectancy is less than one year;
  • (10) Participated in other clinical researchers within the last 3 months.

研究者

相似试验

Randomized controlled clinical trial on the... | 临床试验